Panel of 48 CSF proteins complements existing Alzheimer’s biomarkers
Sep 07, 2023
The CSF 48 panel plus existing biomarkers significantly improved the diagnostic performance for the outcomes studied.
ChatGPT analyzes speech patterns to identify Alzheimer’s 87 percent of the time, researchers show
By
Aaron Dorman
Feb 09, 2024
By reviewing speech patterns, ChatGPT was able to correctly identify Alzheimer’s 87% of the time, a new study shows.
Alzheimer’s disease in Down syndrome similar to autosomal dominant form
May 25, 2022
Age at onset and mortality for Alzheimer’s disease in people with Down syndrome were comparable with fully penetrant form of the disease.
Lecanemab reduced markers of amyloid in early Alzheimer’s disease
Dec 01, 2022
Moderately less decline was seen in cognition and function at 18 months with lecanemab versus placebo.
Holiday season brings new wave of tech toys, games, aimed at older adults, memory care
By
Aaron Dorman
Nov 22, 2023
New tech, as well as updated versions of classic games, are being marketed to older adults as offering more than just entertainment.
As more seniors turn to music therapy, health insurer says it will help payers find their groove
By
Aaron Dorman
Nov 02, 2023
Longevity Health will now provide coverage for a platform that provides music therapy via singing to senior living communities.
Benzodiazepines increase risk of pneumonia in people with dementia: study
By
Lois A. Bowers
Apr 10, 2017
People who have dementia and take benzodiazepines are at a 30% increased risk of developing pneumonia compared with those with dementia taking Z-drugs and those taking neither type of medication, according...
Levetiracetam well-tolerated for Alzheimer’s disease
Oct 01, 2021
It does not improve primary outcome but did improve performance on certain cognitive tasks in those with epileptiform activity.
Gender life expectancy gap increased from 2010 to 2021
Nov 13, 2023
The leading contributors to the widening gender life expectancy gap from 2019 to 2021 included COVID-19 and unintentional injuries.
Most with Alzheimer’s disease, mild cognitive impairment would have been excluded from aducanumab...
Sep 16, 2021
Overall, 92.2, 91, and 85.5% of Medicare beneficiaries with Alzheimer’s disease-related disorders, Alzheimer’s disease, and mild cognitive impairment met at least one of the exclusion criteria.